Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN129,9128,6-1,61
Msft-1,57
Nokia7,1747,2741,21
IBM-0,57
Mercedes-Benz Group AG54,8554,84-0,72
PFE-1,04
14.03.2026 1:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 13.03.2026 21:15:00
Sysco (SYY, NY Consolidated)
Poslední obchod Změna (%) Změna (USD) Objem obchodů (USD)
85,49 0,68 0,58 160 297 008
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 14.03.2026
Popis společnosti

Business Summary: Sysco Corporation is engaged in selling, marketing and distributing food products to restaurants, healthcare and educational facilities, lodging establishments and other customers who prepare meals away from home. It also supplies a variety of non-food items. Its segments include U.S. Foodservice Operations, International Foodservice Operations, SYGMA and Other. U.S. Foodservice Operations segment includes United States Broadline operations and United States Specialty operations. International Foodservice Operations include operations outside of the United States. SYGMA segment includes its United States customized distribution operations serving quick-service chain restaurant customer locations. Other segment includes primarily its hotel supply operations, Guest Worldwide. It distributes various products, such as frozen foods, fresh meats and seafood, dairy products, beverage products, imported specialties, and fresh produce. It operates around 340 distribution facilities worldwide.
Financial Summary: BRIEF: For the 26 weeks ended 27 December 2025, Sysco Corp revenues increased 3% to $41.91B. Net income decreased 3% to $865M. Revenues reflect SYGMA segment increase from $4.16B to $23.27B, U.S. Foodservice Operations segment increase of 47% to $41.72B, International Foodservice Operations segment increase of 6% to $7.97B. Net income was offset by U.S. Foodservice Operations segment income decrease of 2% to $1.7B.



  • Poslední aktualizace: 14.03.2026
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
President, Chief Executive Officer, DirectorUdit Batra5401.09.202001.09.2020
Chief Financial Officer, Senior Vice PresidentAmol Chaubal4912.05.202112.05.2021
Senior Vice President - TA Instruments Division and Clinical Business UnitJianqing Bennett5501.05.202101.05.2021
Senior Vice President - Waters DivisionRobert Carpio4224.06.202424.06.2024